Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Fluorodeoxyglucose F18 × NET × Clear all

Phase

Status

Recruiting 3 Unknown 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4 Breast 3 Gastrointestinal 2 Sarcoma 1 NET 1 Lymphoid 1 Endocrine 1

Conditions

Sarcoma 1 Neuroendocrine Tumors 1 Lymphoma 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1

Interventions

irinotecan sucrosofate 1 PM 01183 1 Injections 1 Fluorodeoxyglucose F18 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Enrolling by invitation

BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡